Dragan Grabulovski
InvestorFounderVenture Partner at Pureos Bioventures · Co-founder and CEO at Araris Biotech
Zurich, Switzerland
Writes $100K – $5M checks · typically $1.5M
FoundedAraris Biotech
About
Dragan Grabulovski is Chief Executive Officer of Araris Biotech AG, a subsidiary of Taiho Pharmaceutical acquired in March 2025. He previously co-founded Covagen, which was sold to Johnson & Johnson in 2014. Grabulovski has experience in founding and scaling biotech companies through successful acquisitions.
Co-founder and CEO at Araris Biotech
Intro paths
→
In turn, Dragan can intro founders to Araris Biotech's investors below.
Araris Biotech's investors · 6
Co-founders at Araris Biotech
PS
Philipp SpycherCo-founder and Chief Scientific Officer
IA
Isabella Attinger-TollerCo-founder
Experience
- Araris Biotech AG, a wholly owned subsidiary of Taiho PharmaceuticalChief Executive Officercurrent2025 — presentZurich, Switzerland
- Pureos BioventuresVenture Partnercurrent2021 — present
- Memo Therapeutics AGStrategic Advisorcurrent2021 — present
- Memo Therapeutics AGActing Chairman2020 — 2021
- Memo Therapeutics AGBoard Member2018 — 2020
- Memo Therapeutics AGStrategic Advisor2017 — 2018
- TopPharmOwner of pharmacy "TopPharm Apotheke Witikon"current2018 — presentApotheke Witikon
- Grabulovski Consulting ServicesCEO and foundercurrent2015 — presentZurich, Switzerland
- Araris Biotech AGCo-founder and Chief Executive Officer2023 — 2025Zurich, Switzerland
- Araris Biotech AGCo-founder and Chairman2019 — 2024Zurich, Switzerland
- Microcaps AGBoard Member2020 — 2023Zurich, Switzerland
- BIOMUNEX PHARMACEUTICALSBoard Observer2016 — 2023Greater Paris Metropolitan Region
- ETH ZürichStartup Coach2017 — 2023Zurich, Switzerland
- Covagen, one of the Janssen Pharmaceutical Companies of Johnson & JohnsonCSO2014 — 2015
- CovagenCSO and co-founder2007 — 2014
- ETH ZurichPhD Student2004 — 2007
- Adler Apotheke & Bahnhof Apotheke WinterthurPharmacist2004
Education
- ETH ZürichPh D
- Rychenberg Gymnasium, WinterthurMatura
Skills & more
Life Sciences14Biotechnology19Antibodies6Protein Engineering7Drug Discovery15Due Diligence1Consulting4Advisory Boards2Lifesciences10Cancer4Molecular Biology9Cell Biology2
+12 more
In VitroProtein ChemistryCell CultureIn VivoImmunologyBiochemistryCellR&DStrategic PlanningManagementPharmaceutical IndustryResearch and Development (R&D)Languages English · French · German · Macedonian · Spanish
From Dragan's professional profile.
Colleagues at Pureos Bioventures
Anne Grahl
Associate at Pureos Bioventures
Butrint Aliu
Analyst at Pureos Bioventures
Christian Altorfer
CFO/COO at Pureos Bioventures
Dominik Escher
Managing Partner at Pureos Bioventures
Klaus Breiner
Managing Partner at Pureos Bioventures
Lars Nieba
Venture Partner at Pureos Bioventures
Luigi Costa
Investor at Pureos Bioventures
Martin Münchbach
Managing Partner at Pureos Bioventures
Network5
Anne Grahl
Associate at Pureos Bioventures
Dominik Escher
Managing Partner at Pureos Bioventures
Klaus Breiner
Managing Partner at Pureos Bioventures
Lars Nieba
Venture Partner at Pureos Bioventures
Luigi Costa
Investor at Pureos Bioventures
Investors connected to Dragan in public investor directories — a warm-intro map.
Frequently asked questions
- Where does Dragan Grabulovski work?
- Dragan Grabulovski is Venture Partner at Pureos Bioventures and Co-founder and CEO at Araris Biotech.
- What check size does Dragan Grabulovski write?
- Dragan Grabulovski typically writes checks of $100K – $5M.
- What companies did Dragan Grabulovski found?
- Dragan Grabulovski founded Araris Biotech.
Founder mafias
ETH Zürich mafia98
Also came through, then founded or led a company.
Thomas DübendorferMastersFounded Spontacts +1Dr. Hanspeter FässlerHonorary Councillor Award (Ehrenrat)Founded Gravis Robotics +1Nikolay KobyshevMaster's DegreeFounded Assaia +1Robin GuldenerBsc.Founded Nango +1Konstantin WohlwendBachelor's degreeFounded Hexclave +1Khalid AshmawyMaster thesisFounded Munify +1
+ 91 more
Pureos Bioventures mafia4
Also came through, then founded or led a company.
Same school
Also attended ETH Zürich212
Bastian HasslingerInvestor at Index VenturesSteve VassalloInvestor at Foundation CapitalHelge DaebelPartner, Head of Water at Emerald Technology Ventures AgMaurin DaiInvestment Manager, Physical AI & Robotics at Emerald Technology Ventures AgChristoph FreiPartner, Head of Energy at Emerald Technology Ventures AgMax HeftiInvestment Director - Energy at Emerald Technology Ventures Ag
+ 206 more
Shared employers
Also worked at Memo Therapeutics AG6
Laura ArgelichAssociate at Ysios CapitalMichael SidlerFounding Partner at redalpineHadrien BouchezPartner at Kurma PartnersButrint AliuAnalyst at Pureos BioventuresMichael HodgesEntrepreneur in Residence at Claris VenturesAndreas WuepperManaging Director; Director Investments, Europe at Fresenius Medical Care Ventures
Also worked at Araris Biotech AG9
Dima KuzminManaging Partner at 4BIO CapitalTherese LiechtensteinPartner at 4BIO CapitalBrian McVeighVenture Partner, USA at 4BIO CapitalArnd KaltofenManaging Partner at VI PartnersMichael SidlerFounding Partner at redalpineDominik EscherManaging Partner at Pureos Bioventures
+ 3 more
Also worked at ETH Zürich86
Max HeftiInvestment Director - Energy at Emerald Technology Ventures AgMichal NatoraSenior Investment Director - Industrial IT & Robotics at Emerald Technology Ventures AgAnnina WinklerSenior Investment Manager - Water & AgriFood at Emerald Technology Ventures AgAndreas GuggenbühlInvestor at Backbone VenturesJoel RoosInvestor at Backbone VenturesPaola BranniInvestor at Extantia Capital
+ 80 more